Future Outlook Of Tissue Culture Reagents Market By 2029| MENAFN.COM

Friday, 09 December 2022 02:29 GMT

Future Outlook Of Tissue Culture Reagents Market By 2029

(MENAFN- America News Hour)

Research Nester released a report titled “Tissue Culture Reagents Market : Global Demand Analysis & Opportunity Outlook 2029″ which delivers detailed overview of the global tissue culture reagents market in terms of market segmentation by therapy type, application and region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The tissue culture reagents market is projected to grow with a moderate CAGR during the forecast period, i.e., 2021-2029 on account of the Extensive research associated with various diseases and treatments in western countries, along with the growing investment in the development of advanced therapies such as vaccines are expected to fuel the progress of this market. According to the data collected from UNICEF, the global immunization coverage by selected antigens are 88% for BCG vaccine, 90% DTP1 vaccine, 85% for DTP3 vaccine, 85% MCV1 vaccine, 71% MCV2 vaccine, 48% PCV3 vaccine, 86% for POL3 vaccine and 39% ROTAC vaccine in 2019.

The market is segmented based on reagent type into media, sera, culture, and others, out of which, the cell culture segment is anticipated to grab the largest share by the end of 2021 due to the primary usage of mammalian cell cultures in the production of mammalian pharmaceuticals and the growing demand for non-conventional drugs developed as a result of bio-production of proteomically and genetically enhanced drugs, this segment is expected witness lucrative growth in demand over the forecast period.

Request Sample For More Information @ 

On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, out of which, the tissue culture reagents market in the Asia Pacific is projected to grow at the highest CAGR throughout the forecast period. Currently, the market in North America holds the largest share. This can be attributed to growing regulatory approvals for cell culture-based vaccines, growing academic and government investments in cell-based research, high life science research funding, high biopharmaceutical R&D expenditure, and the greater adoption of advanced technologies in North America are driving the cell culture market in the region.

Increasing Investments in Research and Development in Life Science Industry to Drive the Market Growth

During 2019-2020, total venture capital funding for the life sciences industry was more than $17 billion.

The growth of this market is majorly driven by the growing awareness about the benefits of cell culture-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing preference for single-use technologies, and the launch of advanced cell culture products.

The growing demand for 3D cell culture, the growing risks of pandemics and communicable diseases, and emerging markets are expected to offer significant growth opportunities for the players operating in the global Cell culture market. On the other hand, the high cost of cell biology research and the lack of proper infrastructure for cell-based research activities are the major factors restraining this market's growth.

Request Sample For More Information @ 

This report also provides the existing competitive scenario of some of the key players of the global tissue culture reagents market which includes company profiling of Becton, Dickinson and Co. (NYSE: BDX), Bio-Techne Corp. (NASDAQ: TECH), Irvine Scientific, Cytiva Life Sciences, Fluidigm Corp. (, NASDAQ: FLDM), GE Healthcare (NYSE: GE), Lonza Group Ltd. (SWX: LONN), Merck KGaA (NYSE: MRK), Sartorius AG (ETR: SRT) and, Thermo Fisher Scientific Inc. (NYSE: TMO). The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global tissue culture reagents market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Also Read Recently Published Press Releases:

Smart Pills Market
Tonometry Market
High Density Cell Banking Market
Upstream Bioprocessing Equipment Market
3D Hip and Knee implants Market

About Research Nester:

Research Nester is a one-stop service provider, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives to make wise decisions for their future investment and expansion by providing them qualitative market insights and strategies while avoiding future uncertainties. We believe in honesty and sheer hard work that we trust is reflected in our work ethics. Our vision is not just limited to gain the trust of our clients but also to be equally respected by our employees and being appreciated by the competitors.


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.